Form 8-K - Current report:
SEC Accession No. 0001104659-24-100709
Filing Date
2024-09-17
Accepted
2024-09-17 17:06:09
Documents
16
Period of Report
2024-09-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2424247d1_8k.htm   iXBRL 8-K 54863
2 EXHIBIT 3.1 tm2424247d1_ex3-1.htm EX-3.1 9475
3 EXHIBIT 3.2 tm2424247d1_ex3-2.htm EX-3.2 7216
4 EXHIBIT 99.1 tm2424247d1_ex99-1.htm EX-99.1 15877
  Complete submission text file 0001104659-24-100709.txt   278302

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA tmb-20240916.xsd EX-101.SCH 3012
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE tmb-20240916_lab.xml EX-101.LAB 34240
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tmb-20240916_pre.xml EX-101.PRE 22358
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2424247d1_8k_htm.xml XML 3714
Mailing Address 12 PENNS TRAIL NEWTOWN PA 18940
Business Address 12 PENNS TRAIL NEWTOWN PA 18940 267-759-3680
Traws Pharma, Inc. (Filer) CIK: 0001130598 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36020 | Film No.: 241305240
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)